-
1Tolerability and efficacy of inhaled AZD4818, a CCR1 antagonist, in moderate to severe COPD patients
المساهمون: Groningen Research Institute for Asthma and COPD (GRIAC)
المصدر: Respiratory Medicine, 104(9), 1297-1303. W B SAUNDERS CO LTD
مصطلحات موضوعية: Male, Pulmonary and Respiratory Medicine, BODE index, medicine.medical_specialty, CP-481,715, Chemokine receptor antagonist, Exacerbation, Deep vein, Placebo, Severity of Illness Index, Pulmonary Disease, Chronic Obstructive, Double-Blind Method, Piperidines, Forced Expiratory Volume, Surveys and Questionnaires, Internal medicine, Severity of illness, medicine, Humans, COPD, Disease modification, Spiro Compounds, Metered Dose Inhalers, Adverse effect, Aged, AZD4818, Dose-Response Relationship, Drug, business.industry, CHEMOKINE RECEPTOR ANTAGONISTS, Middle Aged, medicine.disease, Bronchodilator Agents, Surgery, MICE, Dyspnea, Treatment Outcome, medicine.anatomical_structure, Tolerability, DISEASES, BX471, Female, business, CP-481
-
2دورية أكاديمية
لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل.